BD Biosciences Rolls Out New BD LSRFortessa Cell Analyzer
The new system occupies a 30”x 36″ benchtop footprint, allowing researchers to maximize utilization of the lab space, without sacrificing system power. The system includes a number of
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.
BAL30072 is a new siderophore sulfactam antibiotic. The penicillin-binding-protein inhibition and its bactericidal mode of action confer potent in-vitro and in-vivo activity against Gram-negative bacteria. Pathogens such as